-
1
-
-
38849181710
-
Tumor-induced senescent T cells with suppressor function: A potential form of tumor immune evasion
-
DOI 10.1158/0008-5472.CAN-07-2282
-
Montes CL, Chapoval AI, Nelson J, Orhue V, Zhang X, Schulze DH, et al. Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion. Cancer Res 2008;68:870-9. (Pubitemid 351206765)
-
(2008)
Cancer Research
, vol.68
, Issue.3
, pp. 870-879
-
-
Montes, C.L.1
Chapoval, A.I.2
Nelson, J.3
Orhue, V.4
Zhang, X.5
Schulze, D.H.6
Strome, S.E.7
Gastman, B.R.8
-
2
-
-
27744450650
-
Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy
-
Zhou J, Shen X, Huang J, Hodes RJ, Rosenberg SA, Robbins PF. Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy. J Immunol 2005;175:7046-52. (Pubitemid 41598952)
-
(2005)
Journal of Immunology
, vol.175
, Issue.10
, pp. 7046-7052
-
-
Zhou, J.1
Shen, X.2
Huang, J.3
Hodes, R.J.4
Rosenberg, S.A.5
Robbins, P.F.6
-
4
-
-
20344379893
-
CD28 extinction in human T cells: Altered functions and the program of T-cell senescence
-
DOI 10.1111/j.0105-2896.2005.00256.x
-
Vallejo AN. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 2005;205:158-69. (Pubitemid 40780184)
-
(2005)
Immunological Reviews
, vol.205
, pp. 158-169
-
-
Vallejo, A.N.1
-
5
-
-
33845215290
-
Role of T lymphocyte replicative senescence in vaccine efficacy
-
DOI 10.1016/j.vaccine.2006.08.032, PII S0264410X06009856
-
Effros RB. Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine 2007;25:599-604. (Pubitemid 44856110)
-
(2007)
Vaccine
, vol.25
, Issue.4
, pp. 599-604
-
-
Effros, R.B.1
-
7
-
-
17944390951
-
+ peripheral blood lymphocytes have prognostic value in melanoma patients
-
DOI 10.1016/S0198-8859(03)00122-8
-
Martinez-Escribano JA, Hernandez-Caselles T, Campillo JA, Campos M, Frias JF, Garcia-Alonso A, et al. Changes in the number of CD80(+), CD86(+), and CD28(+) peripheral blood lymphocytes have prognostic value in melanoma patients. Hum Immunol 2003;64:796-801. (Pubitemid 36927643)
-
(2003)
Human Immunology
, vol.64
, Issue.8
, pp. 796-801
-
-
Martinez-Escribano, J.A.1
Hernandez-Caselles, T.2
Campillo, J.A.3
Campos, M.4
Frias, J.F.5
Garcia-Alonso, A.6
Alvarez-Lopez, M.R.7
-
8
-
-
0142010674
-
- T-cell subset of effector cells in the circulation of patients with head and neck cancer
-
DOI 10.1007/s00262-003-0395-6
-
Tsukishiro T, Donnenberg AD, Whiteside TL. Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer. Cancer Immunol Immunother 2003;52:599-607. (Pubitemid 37268192)
-
(2003)
Cancer Immunology, Immunotherapy
, vol.52
, Issue.10
, pp. 599-607
-
-
Tsukishiro, T.1
Donnenberg, A.D.2
Whiteside, T.L.3
-
11
-
-
0035892899
-
IL-7 enhances the survival and maintains the size of naive T cells
-
Rathmell JC, Farkash EA, Gao W, Thompson CB. IL-7 enhances the survival and maintains the size of naive T cells. J Immunol 2001;167:6869-76. (Pubitemid 33144179)
-
(2001)
Journal of Immunology
, vol.167
, Issue.12
, pp. 6869-6876
-
-
Rathmell, J.C.1
Farkash, E.A.2
Gao, W.3
Thompson, C.B.4
-
14
-
-
46949105036
-
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
-
DOI 10.1084/jem.20071681
-
Sportes C, Hakim FT, Memon SA, Zhang H, Chua KS, Brown MR, et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 2008;205:1701-14. (Pubitemid 351962032)
-
(2008)
Journal of Experimental Medicine
, vol.205
, Issue.7
, pp. 1701-1714
-
-
Sportes, C.1
Hakim, F.T.2
Memon, S.A.3
Zhang, H.4
Chua, K.S.5
Brown, M.R.6
Fleisher, T.A.7
Krumlauf, M.C.8
Babb, R.R.9
Chow, C.K.10
Fry, T.J.11
Engels, J.12
Buffet, R.13
Morre, M.14
Amato, R.J.15
Venzon, D.J.16
Korngold, R.17
Pecora, A.18
Gress, R.E.19
Mackall, C.L.20
more..
-
16
-
-
0033136288
-
Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors
-
DOI 10.1016/S1074-7613(00)80052-7
-
Pallard C, Stegmann AP, van Kleffens T, Smart F, Venkitaraman A, Spits H. Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors. Immunity 1999;10:525-35. (Pubitemid 29262655)
-
(1999)
Immunity
, vol.10
, Issue.5
, pp. 525-535
-
-
Pallard, C.1
Stegmann, A.P.A.2
Van Kleffens, T.3
Smart, F.4
Venkitaraman, A.5
Spits, H.6
-
17
-
-
43149095374
-
Discovery of chromone-based inhibitors of the transcription factor STAT5
-
Muller J, Sperl B, Reindl W, Kiessling A, Berg T. Discovery of chromone-based inhibitors of the transcription factor STAT5. Chembiochem 2008;9:723-7.
-
(2008)
Chembiochem
, vol.9
, pp. 723-727
-
-
Muller, J.1
Sperl, B.2
Reindl, W.3
Kiessling, A.4
Berg, T.5
-
18
-
-
3142691373
-
Interleukin-7 inactivates the pro-apoptotic protein bad promoting T cell survival
-
DOI 10.1074/jbc.M401656200
-
Li WQ, Jiang Q, Khaled AR, Keller JR, Durum SK. Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival. J Biol Chem 2004;279:29160-6. (Pubitemid 38915789)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.28
, pp. 29160-29166
-
-
Li, W.Q.1
Jiang, Q.2
Khaled, A.R.3
Keller, J.R.4
Durum, S.K.5
-
19
-
-
25444524850
-
Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity
-
DOI 10.1074/jbc.M502876200
-
Hahn-Windgassen A, Nogueira V, Chen CC, Skeen JE, Sonenberg N, Hay N. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J Biol Chem 2005;280:32081-9. (Pubitemid 41361813)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.37
, pp. 32081-32089
-
-
Hahn-Windgassen, A.1
Nogueira, V.2
Chen, C.-C.3
Skeen, J.E.4
Sonenberg, N.5
Hay, N.6
-
20
-
-
0035905477
-
+ T cells
-
DOI 10.1084/jem.194.12.1711
-
Geginat J, Sallusto F, Lanzavecchia A. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J Exp Med 2001;194:1711-9. (Pubitemid 34028651)
-
(2001)
Journal of Experimental Medicine
, vol.194
, Issue.12
, pp. 1711-1719
-
-
Geginat, J.1
Sallusto, F.2
Lanzavecchia, A.3
-
21
-
-
0032530482
-
Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase
-
DOI 10.1073/pnas.95.19.11211
-
Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci U S A 1998;95:11211-6. (Pubitemid 28450107)
-
(1998)
Proceedings of the National Academy of Sciences of the United States of America
, vol.95
, Issue.19
, pp. 11211-11216
-
-
Delcommenne, M.1
Tan, C.2
Gray, V.3
Rue, L.4
Woodgett, J.5
Dedhar, S.6
-
22
-
-
33644855216
-
Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1
-
DOI 10.1016/j.molcel.2006.02.009, PII S1097276506001110
-
Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 2006;21:749-60. (Pubitemid 43376126)
-
(2006)
Molecular Cell
, vol.21
, Issue.6
, pp. 749-760
-
-
Maurer, U.1
Charvet, C.2
Wagman, A.S.3
Dejardin, E.4
Green, D.R.5
-
23
-
-
18144429102
-
Disruption of Mcl-1-Bim complex in granzyme B-mediated mitochondrial apoptosis
-
DOI 10.1074/jbc.M411377200
-
Han J, Goldstein LA, Gastman BR, Rabinovitz A, Rabinowich H. Disruption of Mcl-1.Bim complex in granzyme B-mediated mitochondrial apoptosis. J Biol Chem 2005;280:16383-92. (Pubitemid 40616768)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.16
, pp. 16383-16392
-
-
Han, J.1
Goldstein, L.A.2
Gastman, B.R.3
Rabinovitz, A.4
Rabinowich, H.5
-
24
-
-
33744507693
-
Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis
-
DOI 10.1074/jbc.M510349200
-
Han J, Goldstein LA, Gastman BR, Rabinowich H. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis. J Biol Chem 2006;281:10153-63. (Pubitemid 43864551)
-
(2006)
Journal of Biological Chemistry
, vol.281
, Issue.15
, pp. 10153-10163
-
-
Han, J.1
Goldstein, L.A.2
Gastman, B.R.3
Rabinowich, H.4
-
25
-
-
66249096306
-
Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim sustains B lymphopoiesis in the absence of IL-7
-
Huntington ND, Labi V, Cumano A, Vieira P, Strasser A, Villunger A, et al. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim sustains B lymphopoiesis in the absence of IL-7. Int Immunol 2009;21:715-25.
-
(2009)
Int Immunol
, vol.21
, pp. 715-725
-
-
Huntington, N.D.1
Labi, V.2
Cumano, A.3
Vieira, P.4
Strasser, A.5
Villunger, A.6
-
26
-
-
76749151403
-
Immune responses to malignancies
-
Whiteside TL. Immune responses to malignancies. J Allergy Clin Immunol 2010;125:S272-83.
-
(2010)
J Allergy Clin Immunol
, vol.125
-
-
Whiteside, T.L.1
-
27
-
-
33749624177
-
Cancer regression in patients after transfer of genetically engineered lymphocytes
-
DOI 10.1126/science.1129003
-
Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006;314:126-9. (Pubitemid 44547756)
-
(2006)
Science
, vol.314
, Issue.5796
, pp. 126-129
-
-
Morgan, R.A.1
Dudley, M.E.2
Wunderlich, J.R.3
Hughes, M.S.4
Yang, J.C.5
Sherry, R.M.6
Royal, R.E.7
Topalian, S.L.8
Kammula, U.S.9
Restifo, N.P.10
Zheng, Z.11
Nahvi, A.12
De Vries, C.R.13
Rogers-Freezer, L.J.14
Mavroukakis, S.A.15
Rosenberg, S.A.16
-
28
-
-
49649114802
-
IL-15 acts as a potent inducer of CD4(+) CD25(hi) cells expressing FOXP3
-
Imamichi H, Sereti I, Lane HC. IL-15 acts as a potent inducer of CD4(+) CD25(hi) cells expressing FOXP3. Eur J Immunol 2008;38:1621-30.
-
(2008)
Eur J Immunol
, vol.38
, pp. 1621-1630
-
-
Imamichi, H.1
Sereti, I.2
Lane, H.C.3
-
29
-
-
34547828312
-
+ T cells, which are increased in active rheumatoid arthritis
-
+ T cells, which are increased in active rheumatoid arthritis. Clin Immunol 2007;124:328-35.
-
(2007)
Clin Immunol
, vol.124
, pp. 328-335
-
-
Yamada, H.1
Kaibara, N.2
Okano, S.3
Maeda, T.4
Shuto, T.5
Nakashima, Y.6
-
30
-
-
67649876115
-
New insights intothe regulation ofT cells by gamma(c) family cytokines
-
Rochman Y, Spolski R, Leonard WJ. New insights intothe regulation ofT cells by gamma(c) family cytokines. Nat Rev Immunol 2009;9:480-90.
-
(2009)
Nat Rev Immunol
, vol.9
, pp. 480-490
-
-
Rochman, Y.1
Spolski, R.2
Leonard, W.J.3
-
31
-
-
16344363217
-
Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor
-
van Herpen CM, van der Laak JA, de Vries IJ, van Krieken JH, de Wilde PC, Balvers MG, et al. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor. Clin Cancer Res 2005;11: 1899-909.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 1899-1909
-
-
Van Herpen, C.M.1
Van Der Laak, J.A.2
De Vries, I.J.3
Van Krieken, J.H.4
De Wilde, P.C.5
Balvers, M.G.6
-
33
-
-
0031749740
-
Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: A clinical phase I study
-
Moller P, Sun Y, Dorbic T, Alijagic S, Makki A, Jurgovsky K, et al. Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study. Br J Cancer 1998;77:1907-16.
-
(1998)
Br J Cancer
, vol.77
, pp. 1907-1916
-
-
Moller, P.1
Sun, Y.2
Dorbic, T.3
Alijagic, S.4
Makki, A.5
Jurgovsky, K.6
-
34
-
-
65249105408
-
Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment
-
Levy Y, Lacabaratz C, Weiss L, Viard JP, Goujard C, Lelievre JD, et al. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest 2009;119:997-1007.
-
(2009)
J Clin Invest
, vol.119
, pp. 997-1007
-
-
Levy, Y.1
Lacabaratz, C.2
Weiss, L.3
Viard, J.P.4
Goujard, C.5
Lelievre, J.D.6
-
35
-
-
67650590873
-
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection
-
Sereti I, DunhamRM, Spritzler J, Aga E, Proschan MA, Medvik K, et al. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 2009;113:6304-14.
-
(2009)
Blood
, vol.113
, pp. 6304-6314
-
-
Sereti, I.1
Dunham, R.M.2
Spritzler, J.3
Aga, E.4
Proschan, M.A.5
Medvik, K.6
-
36
-
-
67349193717
-
Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies
-
Pellegrini M, Calzascia T, Elford AR, Shahinian A, Lin AE, Dissanayake D, et al. Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies. Nat Med 2009;15:528-36.
-
(2009)
Nat Med
, vol.15
, pp. 528-536
-
-
Pellegrini, M.1
Calzascia, T.2
Elford, A.R.3
Shahinian, A.4
Lin, A.E.5
Dissanayake, D.6
-
37
-
-
22544452762
-
Cell biology of IL-7, a key lymphotrophin
-
DOI 10.1016/j.cytogfr.2005.05.004, PII S1359610105000626
-
Jiang Q, Li WQ, Aiello FB, Mazzucchelli R, Asefa B, Khaled AR, et al. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev 2005;16:513-33. (Pubitemid 41022015)
-
(2005)
Cytokine and Growth Factor Reviews
, vol.16
, Issue.4-5
, pp. 513-533
-
-
Jiang, Q.1
Wen, Q.L.2
Aiello, F.B.3
Mazzucchelli, R.4
Asefa, B.5
Khaled, A.R.6
Durum, S.K.7
-
38
-
-
34548833894
-
Interlinking interleukin-7
-
DOI 10.1016/j.cyto.2007.07.183, PII S1043466607003560
-
Kittipatarin C, Khaled AR. Interlinking interleukin-7. Cytokine 2007;39:75-83. (Pubitemid 47446258)
-
(2007)
Cytokine
, vol.39
, Issue.1
, pp. 75-83
-
-
Kittipatarin, C.1
Khaled, A.R.2
-
40
-
-
56849118516
-
Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis
-
Nogueira V, Park Y, Chen CC, Xu PZ, Chen ML, Tonic I, et al. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 2008;14:458-70.
-
(2008)
Cancer Cell
, vol.14
, pp. 458-470
-
-
Nogueira, V.1
Park, Y.2
Chen, C.C.3
Xu, P.Z.4
Chen, M.L.5
Tonic, I.6
-
41
-
-
0033607633
-
Phosphorylation and regulation of Raf by Akt (protein kinase B)
-
Zimmermann S, Moelling K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 1999;286:1741-4. (Pubitemid 129515882)
-
(1999)
Science
, vol.286
, Issue.5445
, pp. 1741-1744
-
-
Zimmermann, S.1
Moelling, K.2
-
42
-
-
2342436459
-
The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development
-
DOI 10.2174/1568009043333032
-
Mitsiades CS, Mitsiades N, Koutsilieris M. The Akt pathway: molecular targets for anti-cancer drug development. Curr Cancer Drug Targets 2004;4:235-56. (Pubitemid 38560073)
-
(2004)
Current Cancer Drug Targets
, vol.4
, Issue.3
, pp. 235-256
-
-
Mitsiades, C.S.1
Mitsiades, N.2
Koutsilieris, M.3
-
43
-
-
17144370268
-
LY294002 and rapamycin co-operate to inhibit T-cell proliferation
-
DOI 10.1038/sj.bjp.0706061
-
Breslin EM, White PC, Shore AM, Clement M, Brennan P. LY294002 and rapamycin co-operate to inhibit T-cell proliferation. Br J Pharmacol 2005;144:791-800. (Pubitemid 40516119)
-
(2005)
British Journal of Pharmacology
, vol.144
, Issue.6
, pp. 791-800
-
-
Breslin, E.M.1
White, P.C.2
Shore, A.M.3
Clement, M.4
Brennan, P.5
-
44
-
-
66149107054
-
Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR
-
Wang CY, Kim HH, Hiroi Y, Sawada N, Salomone S, Benjamin LE, et al. Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR. Sci Signal 2009;2:ra11.
-
(2009)
Sci Signal
, vol.2
-
-
Wang, C.Y.1
Kim, H.H.2
Hiroi, Y.3
Sawada, N.4
Salomone, S.5
Benjamin, L.E.6
-
45
-
-
2342431845
-
Land E1B-19K Proteins Inhibit p53-induced Irreversible Growth Arrest and Senescence by Preventing Reactive Oxygen Species-dependent p38 Activation
-
DOI 10.1074/jbc.M305015200
-
Jung MS, Jin DH, Chae HD, Kang S, Kim SC, Bang YJ, et al. Bcl-xL and E1B-19K proteins inhibit p53-induced irreversible growth arrest and senescence by preventing reactive oxygen species-dependent p38 activation. J Biol Chem 2004;279:17765-71. (Pubitemid 38560543)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.17
, pp. 17765-17771
-
-
Jung, M.-S.1
Jin, D.-H.2
Chae, H.-D.3
Kang, S.4
Kim, S.-C.5
Bang, Y.-J.6
Choi, T.-S.7
Choi, K.-S.8
Shin, D.Y.9
-
46
-
-
34548824056
-
By blocking apoptosis, Bcl-2 in p38-dependent manner promotes cell cycle arrest and accelerated senescence after DNA damage and serum withdrawal
-
Nelyudova A, Aksenov N, Pospelov V, Pospelova T. By blocking apoptosis, Bcl-2 in p38-dependent manner promotes cell cycle arrest and accelerated senescence after DNA damage and serum withdrawal. Cell Cycle 2007;6:2171-7. (Pubitemid 47450419)
-
(2007)
Cell Cycle
, vol.6
, Issue.17
, pp. 2171-2177
-
-
Nelyudova, A.1
Aksenov, N.2
Pospelov, V.3
Pospelova, T.4
-
47
-
-
38349158386
-
Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival
-
Woodland RT, Fox CJ, Schmidt MR, Hammerman PS, Opferman JT, Korsmeyer SJ, et al. Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 2008;111:750-60.
-
(2008)
Blood
, vol.111
, pp. 750-760
-
-
Woodland, R.T.1
Fox, C.J.2
Schmidt, M.R.3
Hammerman, P.S.4
Opferman, J.T.5
Korsmeyer, S.J.6
-
48
-
-
45549099784
-
Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1
-
DOI 10.1056/NEJMoa0800251
-
Hunder NN, Wallen H, Cao J, Hendricks DW, Reilly JZ, Rodmyre R, et al. Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N Engl J Med 2008;358:2698-703. (Pubitemid 351860862)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.25
, pp. 2698-2703
-
-
Hunder, N.N.1
Wallen, H.2
Cao, J.3
Hendricks, D.W.4
Reilly, J.Z.5
Rodmyre, R.6
Jungbluth, A.7
Gnjatic, S.8
Thompson, J.A.9
Yee, C.10
-
49
-
-
0035902080
-
Progress in human tumour immunology and immunotherapy
-
DOI 10.1038/35077246
-
Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature 2001;411:380-4. (Pubitemid 32467048)
-
(2001)
Nature
, vol.411
, Issue.6835
, pp. 380-384
-
-
Rosenberg, S.A.1
-
50
-
-
77954801079
-
Improved survival with ipilimumab in patients with metastatic melanoma
-
Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711-23.
-
(2010)
N Engl J Med
, vol.363
, pp. 711-723
-
-
Hodi, F.S.1
O'Day, S.J.2
McDermott, D.F.3
Weber, R.W.4
Sosman, J.A.5
Haanen, J.B.6
|